Onshoring and reshoring is real says Circuitwise

The hope that the Covid-19 pandemic will bring some good by forcing companies to re-engineer supply chains from overseas to local sources is real, according to electronics manufacturer and assembler Circuitwise Electronics Manufacturing. While local manufacturers turned to the half dozen large Australian printed circuit board makers at the height of pandemic disruption, the first…

AML3D to 3D print lifting device for Austal shipbuilding

Additive Manufacturing technology company AML3D has received a purchase order from Perth-based international shipbuilder Austal to produce a prototype Davit arm lifting device for mounting on its ships. The contract follows a MOU signed by Austal and AML3D as as reported by @AuManufacturing news. AML3D has now completed the design and optimisation phase of the…

SAAB to onshore defence health system business

SAAB Australia is to relocate its global Deployable Health System Design and Development Centre from Europe to Australia following the win of a $370 million defence contract to deliver cutting-edge deployable health equipment. The first five-years of the contract will see Saab Australia enhance the ADF’s clinical health care response capability by delivering more than…

Glaciem wins engineering award for CO2 Refrigeration

South Australia’s Glaciem Cooling Technologies has won the state’s Engineering Excellence Award and been named as Sir William Hudson Award finalist. The company was recognised for several technologies based on research at the University of South Australia. Their air-cooled CO2 refrigeration system has been operating at The Bend Motorsport Park, about 100km southeast of Adelaide,…

1414 Degrees looks to add batteries to silicon energy storage

Thermal energy storage developer 1414 Degrees has evaluated its TESS molten silicon technology for energy storage under scenarios linked to additional battery storage. The company, which is developing the Silicon Aurora project near Port Augusta in South Australia, found the project would generate higher revenues by combining thermal (TESS) and battery enetrgy (BESS) storage. The…

Recce Pharmaceuticals raises $29 million

Anti-infective drug developer Recce Pharmaceuticals has received commitments from investors for $27,950,000 to be raised in a placement of shares. The capital raising will fast track commercialisation activities and fund human clinical trials. The company has been developing broad spectrum synthetic drugs which have achieved ‘positive results’ in pre-clinical laboratory and animal tests on E.…